Quiver Bioscience develops medicines for brain disorders using human disease models and advanced AI technologies.
Quiver Bioscience has raised $9.3M in total funding. The most recent round was Grant. The last funding was announced in May 2026.
Quiver Bioscience's investors include National Institutes of Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke, Porta.
Quiver Bioscience is headquartered in Cambridge, United States.
Quiver Bioscience develops medicines for brain disorders using human disease models and advanced AI technologies.
Quiver Bioscience is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Quiver Bioscience — Funding & Investors." VCBacked, May 4, 2026, https://www.vcbacked.co/company/quiver-bioscience. Accessed July 19, 2026.
VCBacked. (2026). Quiver Bioscience — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/quiver-bioscience
{{cite web |title=Quiver Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/quiver-bioscience |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated